Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $671.53 billion, total revenue of $168.84 billion and a weighted average PE ratio of 38.62.
Market Cap
671.53B
Revenue
168.84B
Profits
17.39B
PE Ratio
38.62
Profit Margin
10.30%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 175.66B | 0.61% | 2,756,024 | 44.56B |
| 2 | DHR | Danaher Corporation | 137.93B | 1.91% | 3,747,050 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 46.75B | 0.13% | 413,009 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 31.86B | 0.81% | 2,088,141 | 7.07B |
| 5 | WAT | Waters Corporation | 29.13B | 2.40% | 1,500,457 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.63B | 2.30% | 1,449,524 | 16.31B |
| 7 | NTRA | Natera, Inc. | 27.66B | 0.15% | 1,140,554 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 24.53B | 0.67% | 124,616 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 22.27B | 1.27% | 508,733 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.81B | -0.33% | 791,244 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 19.84B | 0.06% | 1,453,047 | 3.25B |
| 12 | ILMN | Illumina, Inc. | 18.50B | 1.43% | 1,362,190 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.91B | 0.30% | 326,653 | 2.53B |
| 14 | GH | Guardant Health, Inc. | 11.64B | 1.78% | 1,161,525 | 982.02M |
| 15 | RVTY | Revvity, Inc. | 9.78B | 1.20% | 929,044 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 9.01B | 1.55% | 1,761,890 | 2.09B |
| 17 | ICLR | ICON Public Limited Company | 7.67B | 2.89% | 826,110 | 8.10B |
| 18 | CRL | Charles River Laboratories International, Inc. | 7.54B | 0.82% | 737,463 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 4.93B | -0.82% | 1,042,902 | 2.04B |
| 20 | SHC | Sotera Health Company | 3.94B | 2.06% | 2,229,124 | 1.16B |
| 21 | BLLN | BillionToOne, Inc. | 3.25B | -0.98% | 252,764 | 305.11M |
| 22 | TWST | Twist Bioscience Corporation | 2.90B | 5.11% | 936,015 | 391.56M |
| 23 | VCYT | Veracyte, Inc. | 2.66B | 1.76% | 701,501 | 517.15M |
| 24 | WGS | GeneDx Holdings Corp. | 2.21B | -0.78% | 419,352 | 427.54M |
| 25 | GRAL | GRAIL, Inc. | 1.94B | 3.48% | 521,134 | 147.17M |
| 26 | NEO | NeoGenomics, Inc. | 1.07B | 0.36% | 1,014,140 | 727.33M |
| 27 | OPK | OPKO Health, Inc. | 913.56M | - | 1,826,271 | 606.88M |
| 28 | CDNA | CareDx, Inc. | 901.66M | 1.65% | 379,891 | 379.81M |
| 29 | CSTL | Castle Biosciences, Inc. | 768.85M | 0.12% | 349,679 | 344.23M |
| 30 | PSNL | Personalis, Inc. | 744.98M | 4.86% | 772,645 | 69.65M |
| 31 | FLGT | Fulgent Genetics, Inc. | 482.51M | 3.34% | 1,078,206 | 322.67M |
| 32 | BNR | Burning Rock Biotech Limited | 452.76M | 1.12% | 24,404 | 77.14M |
| 33 | MYGN | Myriad Genetics, Inc. | 447.90M | 4.36% | 2,034,990 | 824.50M |
| 34 | PRE | Prenetics Global Limited | 351.88M | -3.77% | 128,099 | 92.39M |
| 35 | MDXH | MDxHealth SA | 165.32M | -0.89% | 47,059 | 107.88M |
| 36 | BDSX | Biodesix, Inc. | 162.71M | -4.54% | 106,414 | 88.50M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 129.28M | -0.66% | 131,758 | 4.40M |
| 38 | FONR | FONAR Corporation | 120.89M | 0.11% | 26,116 | 106.03M |
| 39 | XGN | Exagen Inc. | 76.73M | 0.95% | 383,185 | 66.58M |
| 40 | PRPO | Precipio, Inc. | 49.97M | 3.71% | 18,233 | 22.80M |
| 41 | NOTV | Inotiv, Inc. | 13.21M | 6.31% | 187,584 | 514.03M |
| 42 | MBAI | Check-Cap Ltd. | 12.86M | -0.84% | 22,880 | - |
| 43 | BIAF | bioAffinity Technologies, Inc. | 12.28M | 42.93% | 118,702,284 | 6.16M |
| 44 | XWEL | XWELL, Inc. | 8.19M | 1.43% | 113,742 | 29.52M |
| 45 | ADVB | Advanced Biomed Inc. | 4.99M | -15.10% | 20,787 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 3.81M | -0.91% | 9,334 | - |
| 47 | ISPC | iSpecimen Inc. | 2.16M | 12.67% | 33,999,673 | 3.35M |